Gut microbiota metabolites can directly or indirectly regulate brain activity through neuroendocrine and other pathways. Bacterial metabolites such as SCFAs, bile acids, vitamins, and other substances have direct effects. SCFAs are the main products of dietary fiber fermentation by intestinal microorganisms. They are mainly composed of acetate, propionate, butyrate, etc.; after being absorbed by intestinal epithelial cells, they pass through the portal vein to the liver, and through the systemic circulation directly communicate with the CNS (Dalile et al., 2019). In this case, SCFAs produced by gut microbiota, such as F. prausnitzii, Eubacterium rectale, Bacteroides, act on the hippocampus through the BBB and regulate neurogenesis (Tan et al., 2019). As an important metabolite of gut microbiota, the activation of SCFAs and their receptors play an important role in the regulation of neurogenesis: Butyrate activates receptors GPR41 (FFAR3) and GPR43 (FFAR2), enhances pituitary growth hormone release, and promotes brain neurogenesis (Aberg, 2010; Miletta et al., 2014); Mice lacking FFAR2 (Ffar2^-/- ) showed microglial cell morphology, dysfunction and cellular defects. FFAR2 signaling was also found to be expressed on splenic Iba-1⁺ myeloid cells in the red marrow, thus SCFAs may interact with FFAR2 receptors in peripheral myeloid cells to maintain normal microglia function and may be involved in the regulation of neurogenesis (Erny et al., 2015); Intervention with butyrate (histone deacetylase inhibitor) reduced cell proliferation and significantly increased apoptotic cells. In contrast, activation of the butyrate receptor GPR41 (FFAR3) reduced the elevation of histone acetylation and prevented the anti-proliferative and pro-apoptotic effects of butyrate (Wu et al., 2012). At the same time, some studies directly show that SCFAs are involved in the regulation of neurogenesis, compared with the control group, SCFAs intervention promoted the proliferation of hNPCs, and changed the expression of genes related to neurogenesis, proliferation and apoptosis, such as neurogenesis related genes Atr, Ndn, proliferation related genes Cdk2, E2f1, Vegfa, and apoptosis related genes Bcl2, Bid, Casp8, Fas (Yang L. L. et al., 2020); of these, physiological concentrations of SCFAs (acetate: butyrate: propionate in a ratio of approximately 30:1:2) all increased the proliferation rate of hNPCs. At the same order of magnitude, butyrate exerted a better effect on neurogenesis (Yang L. L. et al., 2020). In addition, systemic injection of sodium butyrate up-regulated histone hyperacetylation in the brain and liver, upregulating brain-derived neurotrophic factor (BDNF), nerve growth factor, and glial cell, glial cell line-derived neurotrophic factor (GDNF) expression in mouse hippocampus after intracerebroventricular injection of sodium butyrate (Varela et al., 2015). Bill acids have played a unique role in influencing the activities of the central nervous system. Although bile acids may be synthesized locally in the brain, they are mostly absorbed from the systemic circulation. In the brain, cytochrome P450 46A1 (CYP46A1) is involved in cholesterol clearance (Lorbek et al., 2012), this provides raw materials for bile acid synthesis. While bile acids also are synthesized in the liver and secreted to the intestine. After being modified by the gut microbiota, they are transported to the liver through the portal vein. A small amount of bile acids enters the brain through the BBB through the systemic circulation (Monteiro-Cardoso et al., 2021). In this scenario, the gut microbiota influences neurogenesis via the bile acid metabolism pathway. Tauroursodeoxycholic acid promotes NSCs proliferation and differentiation in mouse SGZ, and regulates mitochondrial function and cell cycle signals (Xavier et al., 2014; Soares et al., 2018); this phenomenon may also be related to lipid metabolism (Fernandes et al., 2020). Tauroursodeoxycholic acid produced by modification of gut microbiota regulates NSCs differentiation after blood circulation into the brain (Song et al., 2017; Chen et al., 2020b). The gut microbiota can often provide the host with a source of vitamins, the most common are Vitamin K, Vitamin C, and Vitamin B (folic acid), which may also regulate neurogenesis (Steinert et al., 2020). Compared with the control group, Notch1 and Hes1 expressions were up-regulated and the Mash1 expression was down-regulated after folic acid administration. Folic acid activates Notch signaling, promoting the proliferation of hippocampal NSCs (Zhang et al., 2008; Zhang et al., 2012). Warfarin, an antagonist of Vitamin K, induced the proliferation of SVZ cells, and Vitamin K significantly reversed this phenomenon after the intervention, which may be related to Vitamin K-dependent proteins (Gely-Pernot et al., 2012). Meanwhile, a Vitamin K derivative, methylnaphthoquinone, could also regulate neuronal differentiation of NPCs (Sakane et al., 2017). Vitamin C also appears to play a potential role in regulating neurogenesis, increasing the number of DCX-positive neuroblasts and BrdU⁺-NeuN⁺ cells in the hippocampal DG. This is possibly related to the upregulation of BDNF expression (Nam et al., 2019). The tryptophan in dietary proteins is metabolized by metabolic enzymes in the gut microbiota to produce indole, tryptamine, etc. across the intestinal tight junction, or induce enterochromaffin cells (ECCs), enteroendocrine L-cells, etc. to release a series of substances to affect host activities (Roager and Licht, 2018). Compared with the specific pathogen-free control mice group, the content of indole derivatives in the serum of the germ-free (GF) group decreased as did neurogenesis. From this, we can infer that indole has an effect on neurogenesis after crossing the BBB (Wei et al., 2021). Moreover, indole supplementation up-regulated postsynaptic density protein-95 (PSD-95) and synaptophysin (SYP) expression in the hippocampus of WT C57BL/6J mice, while activating the Wnt/β-catenin pathway and up-regulating its downstream targets VEGF and Neurog2 (Wei et al., 2021). SCFAs, indoles, bile acids, and gut microbiota produce and secrete serotonin (5-HT) by affecting ECCs (Benninghoff et al., 2010; Morris et al., 2017; Legan et al., 2022); the 5-HT produced in the gut cannot directly cross the BBB (Legan et al., 2022). However, tryptophan can cross the BBB and serve to synthesize 5-HT in the brain, which stimulates the corresponding receptors in different neurogenic regions to induce proliferation and neurogenesis: 5-HT1A heteroreceptor are involved in DG and SVZ; 5-HT1B autoreceptors modulate the role of 5-HT in SVZ and DG, 5-HT1B heterotypic receptors regulate cell proliferation in SGZ; 5-HT2A and 5-HT2C receptors selectively regulate cell proliferation in SGZ and SVZ. (Banasr et al., 2004; Liu N. et al., 2021). Taken together, some gut microbiota metabolites which cross the BBB could potentially regulate CNS activity, including neurogenesis.

The neuronal connections of the MGB axis underlie the fastest and most direct brain-gut interaction; the gastrointestinal tract interacts with the brain through the autonomic nervous system, of which the vagus nervous system is the main driver (Bonaz et al., 2018; Morais et al., 2021). The vagus nerve descends through the enteric nervous system to the gut, and enteric ganglia and nerve fibers make up two major plexuses: the submucosal and the myenteric nerve plexis (Wang and Powley, 2007). As a second brain, enteroendocrine cells are the first-order neurons underlying brain-gut interactions (Kaelberer et al., 2018). Gut microbiota metabolites stimulate Enteroendocrine L-cell, ECCs to generate 5-HT, glucagon like peptide-1 (GLP-1), cholecystokinin and other substances, and transmit signals to the enteric nervous system (Bellono et al., 2017; Kuwahara et al., 2020). On the one hand, ECCs secreted peptides/hormones act directly on vagal afferent fibers (Latorre et al., 2016), and on the other hand, secretions from the ECCs communicate with the vagus nerve via the enteric nervous system, intrinsic primary afferent neurons (Kuwahara et al., 2020). The vagus nerve might be involved in neurogenesis as evidenced by the fact that compared with the control group, capsaicin treatment resulted in unmyelinated vagus nerve injury, significantly reducing the number of doublecortin-positive cells in the DG and activated microglia (Ronchi et al., 2012). In another study, transplantation of fecal microbiota from old mice into young mice reduced neurogenesis, a process that may be related to decreased vagal activity (Rei et al., 2022). This suggests that the neuronal pathways of MGB axis could be involved in the regulation of glia and neurogenesis. First, the vagus nerve stimulates microglia activation in pathological conditions. For instance, in AD, the number of microglia branches and total branch length were significantly different under non-invasive vagus nerve stimulation (Kaczmarczyk et al., 2017). At the same time, vagus nerve stimulation down-regulated Toll-like receptor 4 (TLR4) expression in microglia in the acute phase of stroke and promoted microglia polarization to the M2 phenotype (Zhang et al., 2021). In addition, the vagus nerve regulates BDNF content in the brain; after vagotomy, BDNF expression in the hippocampus is down-regulated and hippocampal cell proliferation, neonatal cell survival, and neurogenesis were reduced. Therefore, mouse gut microbiota could induce changes in hippocampal BDNF and affect neurogenesis through the vagal pathway (Bercik et al., 2011; O’Leary et al., 2018). L. rhamnosus (JB-1) feeding upregulates the receptors for γ-aminobutyric acid (GABA) GABA_Aα2 receptor expression in the DG and CA3 regions (Bravo et al., 2011), while simultaneously down-regulating GABA_Aα1 receptor expression in DG, CA3, and CA1; this phenomenon was reversed after sub-diaphragmatic vagotomy (Bravo et al., 2011). In general, GABA_A activation inhibits cell proliferation, affects migration, maturation and differentiation (Pallotto and Deprez, 2014). At the same time, the dorsal vagal complex of the adult brain stem is a neurogenic region (Bauer et al., 2005; Charrier et al., 2006), the vagus nerve perceives sensory stimulation from gut microbiota and transmits to this region to affect neurogenesis. For example, ghrelin regulates the secretion of growth hormone and energy balance of the dorsal motor nucleus of the vague, and promotes neuronal proliferation, but at present there is controversy about which way to mediate (Zhang et al., 2004; Perello et al., 2022). In addition, vagus nerve stimulation activates the nucleus tractus solitarii; preproglucagon neurons in the nucleus tractus solitarii are the main source of GLP-1 in the brain (Holt et al., 2019; Cooper et al., 2021). The GLP-1 analog (Val8) increases the number of BrdU⁺ cells in the DG of the hippocampus and DG neurogenesis compared to controls (Mcgovern et al., 2012), as did two other GLP-1 analogs, Exendin-4 and liraglutide (Hamilton et al., 2011). Therefore, the vagus nerve could modulate neurogenesis by affecting central GLP-1 levels.

The crosstalk between gut microbiota and immune system is the basis for the connections between the brain and microorganisms through immune pathways. The CNS and gut microbiota can interact through the immune system, which is also affected by the CNS and gut microbiota (Zheng et al., 2020). Some studies show that gut microbiota and metabolites affect brain microglia cells, which may further affect neurogenesis. Compared with the control group, the expression of activated genes such as Mapk8 or Fcgr2β in the microglia of the GF mice group was down-regulated as was B2m gene expression (the MHC class I related β2 microglobulin) and the microglia tended to be immature M0 type (Erny et al., 2015), these reveals the defect of microglia in GF mice; but the conditions were reversed after colonization and SCFAs diet (Erny et al., 2015). Therefore, we think that gut microbe-derived SCFAs enter the systemic circulation and cross the BBB to regulate microglial activity (Huuskonen et al., 2004). The gut microbiota affects BBB permeability as shown by increased BBB permeability in GF mice relative to control mice (Braniste et al., 2014); the expression of occludin and claudin-5 in the GF frontal cortex, striatum and hippocampus was reduced and the number of intact tight junctions significantly reduced (Braniste et al., 2014). In addition, there are other potential mechanisms by which the microbiota regulates microglia and astrocytes, such as microbe-associated molecular patterns, vagus nerve pathways, etc. (Wang Y. et al., 2018). For example, intestinal microbial metabolites such as H₂S stimulate the vagus nerve and regulate microglial polarization (Chen et al., 2022; Ni et al., 2022), which regulates NSCs proliferation and differentiation (Shigemoto-Mogami et al., 2014). In some cases, the peripheral immune system can affect the central immune system. Similarly, some peripheral cytokines may enter the CNS through an abnormal BBB, neural route, and immune cell infiltration (Beurel et al., 2020). Therefore, changes in the gut microbiota may modulate the central immune system and glial function and could therefore have various effects on neurogenesis, a hypothesis confirmed by some studies. Antibiotics decreased Ly6Chi monocyte populations and neurogenesis in the mouse brain and bone marrow. These effects were reversed by probiotic treatment (Mohle et al., 2016). This suggests that Ly6Chi monocytes play a mediate between gut microbiota and neurogenesis. IL-4-driven microglia in the CNS activates the BDNF-TrkB pathway to induce neurogenesis in the hippocampus (Zhang J. et al., 2021). IFN-γ injection into the ventricle increased density and area of mouse hippocampal glial cells, activated microglia-mediated neuroinflammation, increased TNF-α, iNOS, etc. (Zhang J. et al., 2020) while inhibiting neural stem/precursor cells (NSPCs) proliferation and promoted the apoptosis of immature neurons (Zhang J. et al., 2020). In addition, the microglial activation-derived miR-146a-5p downregulates kruppel-like factor 4(KLF4) and cyclin-dependentkinase-like 5(CDKL5) expression in the DG region of rats, inhibiting NSCs proliferation and differentiation (Fan et al., 2022). Normal mice transplanted with fecal bacteria from AD mice developed memory impairment and reduced neurogenesis in the hippocampus, while TNF-α and IL-1β increased BDNF expression was downregulation (Kim et al., 2021). Moreover, changes in gut microbiota of mice can lead to increased colitis (Kim et al., 2021), characterized by changes in gut microbiota, like increased abundance of Verrucomicrobia and Proteobacteria. In such a situation, IFN-γ, IL-1β, TNF-α were up-regulated in the distal colon, resulting in microglial activation in adulthood and impaired hippocampal neurogenesis (Salvo et al., 2020). This evidence suggests that alterations in the gut microbiota modulate CNS immunity and alter glial function, which may affect neurogenesis.

Bacteroidetes maintain the balance of gut microbiota and are closely related to CNS diseases. For example, increased Bacteroidetes levels were found in patients with AD, major depressive disorder, and myasthenia gravis (Jiang et al., 2015; Vogt et al., 2017; Moris et al., 2018), and decreased levels in patients with PD (Unger et al., 2016). At the same time, changes in Bacteroidetes abundance are accompanied by changes in microglia, astrocytes, etc. (Shi et al., 2021). This suggests that Bacteroidetes may regulate NSCs and neurogenesis. Curcumin treatment corrected the relative abundance of Bacteroidetes in a mouse anxiety model, increasing SCFAs content in the feces, affecting the glycerophospholipid metabolism in the prefrontal cortex, possibly by regulating circulatory pathways (Zhang et al., 2022). In another study, cAMP-response element binding protein activation enhanced BDNF expression by increasing glycerophospholipids (Hossain et al., 2022). Meanwhile, Curcumin intervention up-regulated 5-HT(1a) receptor and BDNF, increasing neurogenesis (Xu et al., 2007). This suggests that curcumin may modulate neurogenesis by affecting chemical pathways in the MGB axis by modulating Bacteroidetes activity. In addition, Scutellaria baicalensis Georgi also exerts similar pharmacological effects in brain injuries induced by diabetes, mice treated with Astragalus membranaceus reduced Bacteroidetes abundance, upregulation of BDNF expression and promotion of hippocampal mitogenesis (Li X. et al., 2022). Baicalin, an effective component of Scutellaria baicalensis Georgi, reduces the abundance of parabacteroides, prevotella, and Bacteroides in mouse intestine, reducing the proinflammatory factors IL-1β, IL-6 and TNF-α in the cerebral cortex (Gao et al., 2018b); in the DG, it promotes cell proliferation and differentiation, and upregulates hippocampal Wnt/β-catenin signaling pathway related protein expression (Xiao et al., 2021). This suggests that the gut microbiota may influence neurogenesis by affecting brain inflammation. Similarly, Astragalus and its active components affect neurogenesis through MGB axis immune pathways, which may be related to microglia activation (Li et al., 2020), but the specific mechanism needs to be further confirmed. In vitro, Astragaloside VI promotes the differentiation of primary NSCs into neurons and astrocytes, similarly to Astragalus flavor, which up-regulated Notch1, Jagged1, Mash1, Ngn1, and Ngn2 expression in NSCs (Gao et al., 2022). Epigallo-catechin-3-gallate (EGCG), the main component of Camellia sinensis (green tea), increases the abundance of Bacteroides uniformis, Bacteroides vulgatus, Bacteroides stercoris, Bacteroides thetaiotaomicron, and Bacteroides cellulosilyticus in human gut microbiota (Liu Z. et al., 2020). In preclinical studies, EGCG enhanced hippocampal neurogenesis, improved learning and memory in mice, and upregulated SHH, Ptch and Gli1 expression in the mouse hippocampus (Wang et al., 2012). Crossing the intestinal epithelial barrier and the BBB regulates hippocampal neural differentiation after EGCG interacts with the gut microbiota (Faria et al., 2011; Granja et al., 2019). Qisheng Wan formula increased Bacteroidetes abundance in AD mice while reducing NF-κB, IL-6, and TNF-α content (Xiong et al., 2022); one of its active ingredients, Polygala tenuifolia, promotes APP-NSCs proliferation and migration and neuronal differentiation (Wang X. F. et al., 2021), while another ingredient, Acorus tatarinowii Schott, also affects neurogenesis, microglial function and can activate PKA-CREB signaling, enhancing nerve growth factor induced differentiation and neurite length of PC12 cells (Cai et al., 2016; Lam et al., 2016). Lipopolysaccharide, amyloids, and other substances produced by Bacteroidetes affect neuroinflammation, possibly by regulating the brain inflammatory microenvironment to regulate neurogenesis (Zhao and Lukiw, 2018), as confirmed by the effects of TCM presented above. In summary, most TCM compounds regulate neurogenesis by interfering with the chemical and immune pathways of the MGB axis, accompanied by changes in Bacteroidetes abundance.

Firmicutes transplantation can be used in the treatment of brain diseases. Lactobacillus, as a unique Firmicutes of bacteria, is one of the important microbiota for maintaining the micro-ecological health of the human gut, some studies have found increased 5-HT and BDNF concentration in the serum of constipated patients who received Lactobacillus reuteri DSM-17938 (Riezzo et al., 2019), Lactobacillus rhamnosus HN001 could effectively prevent and treat postpartum depression (Slykerman et al., 2017). This evidence indicates that Firmicutes may regulate brain activity and treatment of central nervous system diseases and injuries. Using a Buyang Huanwu Decoction (BHD) in cerebellar ischemia model mice significantly down-regulated the relative abundance of Streptococcus, Coprococcus_2, Enterococcus, etc, and while up-regulating the relative abundance of Lactobacillus, Ruminococcaceae_UCG-002, etc. (Tang R. et al., 2022). This lowered the levels of proinflammatory cytokines in peripheral blood and inhibited microglial activation (Tang R. et al., 2022). At the same time, BHD promoted NSCs proliferation in middle cerebellar artery occlusion mice and promoted astrocyte and neuronal differentiation, which may be related to Jak/Stat3/Cyclin D1 and EGFR/PI3K/Akt/Bad/14-3-3 pathways (Chen X. et al., 2020). The altered abundance of Firmicutes after BHD intervention may affect peripheral and central immunity, thus regulating NSCs proliferation and differentiation. In addition, curcumin promoted hippocampal neurogenesis and enhanced NSCs proliferation in APP/PS1 mice, up-regulating Hes1 and NICD expression and activating the Notch pathway (Li et al., 2019). In the gut of APP/PS1 mice, curcumin down-regulated the abundance of Lactobacillaceae, producing substances such as demethylcurcumin and bisdemethoxycurcumin which alleviate the pathological changes of AD (Sun et al., 2020). Changes in the gut microbiota may modulate gene expression in neurogenesis-related pathways; however, there is currently no clear evidence for the specific mechanisms. In some mental diseases, curcumin increases the content of 5-HT, BDNF, etc. in the hippocampus, and modulates related signaling changes in the peripheral intestinal system (Yu et al., 2015); this may be related to the hypothalamic-pituitary-adrenal (HPA) axis of the MGB axis, as curcumin reduces the ratio of adrenal gland weight to body weight and adrenal cortex thickness, down-regulating serum corticosterone levels and up-regulating hippocampal glucocorticoid receptor expression (Xu et al., 2006). In the SGZ, andrographolide promotes NSCs proliferation and neurogenesis, up-regulating hippocampal β-catenin expression, inhibiting GSK-3β activity, and up-regulating the expression of Wnt target gene NeuroD1 (Varela-Nallar et al., 2015). Moreover, Andrographolide increased the abundance of Firmicutes in the gut, significantly reducing neuroinflammation in mouse brain tissue and enhancing BDNF expression (Saha et al., 2021). This suggests that Andrographolide may affect BDNF expression through the MGB axis, affecting Wnt signaling in NSCs (Yang et al., 2016; Li et al., 2017), and may be involved in neuroinflammation. Increased abundance of intestinal Firmicutes in AD mice after Ginkgolide B treatment could improve AD pathology and cognitive dysfunction (Liu J. et al., 2021). In vitro, Ginkgolide B promotes NSCs neuronal differentiation in the SVZ, activates the Wnt/β-catenin pathway, and upregulates the target gene Axin2 (Li et al., 2018). This may be related to the Firmicutes regulating the permeability of the BBB and promoting Ginkgolide B to cross the BBB to regulate hippocampal activity (Lin et al., 2022). In addition, Resveratrol packaged with selenium nanomaterials (TGN-Res@SeNPs) reversed the alterations of Firmicutes in AD, increasing Lactobacillus, Lachnospiraceae_NK4A136_group, etc (Li et al., 2021); after treatment, levels of neurotransmitters such as glutamate and GABA recovered in the hippocampus of mice, increased total antioxidant capacity (T-AOC), CAT, GSH-Px, and IL-10 levels in mouse brain tissue and decreased MDA, IL-1β, IL-6, TNF-α (Li et al., 2021). This may be because Resveratrol modulates the abundance of Firmicutes, such as Lachnospiraceae_NK4A136_group, which are closely related to inflammation and oxidation and may affect neurogenesis by altering the microenvironment (Li and Barres, 2018). A high-fat diet can damage cognitive function, which may be related to neuroinflammation (Huang and Yun, 2020). When high-fat diet mice were treated with a water extract from a processed Polygonum multiflorum modulate, a significant decrease in the relative abundance of Firmicutes was observed (Gu et al., 2020); in addition, Polygonum multiflorum Thunberg complex orally Composition-12 (PMC-12) promoted cell proliferation and neuronal differentiation in the DG and significantly up-regulated BDNF and p-CREB expression in the hippocampus. However, the underlying mechanism by which Polygonum multiflorum affects the MGB axis remains unclear (Park et al., 2016).

Changes in Proteobacteria can predict changes in the total brain and cortex of rhesus monkeys in infancy (Rendina et al., 2021). Proteobacteria levels differ between healthy individuals, and those with mild cognitive impairment and AD; these difference gradually increase with disease deterioration (Guo et al., 2020). The density of DCX-positive cells in the DG of Bilophila wadsworthia (Belongs to Proteobacteria) colonized mice decreased, showing a similar effect on mouse hippocampus to that of a ketogenic diet, affecting hippocampal neurogenesis (Olson et al., 2021). Berberine, a TCM compound, could increase the abundance of dopa/dopamine producing bacteria such as Escherichia-Shigella and Pseudomonas (Wang Y. et al., 2021). Berberine neuronal differentiation of C17.2 NSCs in vitro, upregulates Nestin, microtubule-associated protein 2 (MAP2) and tubulin β 3 Class III (TUBB3) expression, this indicates that the proliferation and neuronal differentiation of NSCs are promoted after the intervention. This may be closely related to the activation of Wnt/β-catenin pathway (Shou et al., 2019). Berberine might affect central dopamine production by regulating Proteobacteria abundance, further affecting Wnt/β-catenin through Dopamine D2 receptor to promote neurogenesis in PD (Marchetti et al., 2022). Ginsenoside Rg1 was shown to reduce tau content in the hippocampus of AD model and upregulated Proteobacteria abundance (Wang S. et al., 2020), promoting NSCs growth and proliferation, down-regulating β-catenin, C-myc expression and upregulating GSK-3β expression (Xiang et al., 2019). This may be caused by changes in bacterial tryptophan metabolism, reducing peripheral blood 5-HT levels and affecting hippocampal neurotransmitters, thereby regulating NSCs proliferation and differentiation (Chen et al., 2022); however, the specific mechanism warrants further research. Similarly, BHD decreased the abundance of Escherichia-Shigella and Klebsiella (Tang R. et al., 2022). The combination of Puerariae Lobatae Radix (PLR) and Chuanxiong Rhizoma (CXR) could partially reduce the enrichment of intestinal pathogens Escherichia_Shigella, Proteus, Klebsiella, etc. in a mouse model of ischemic stroke (Chen R. et al., 2019). Plasma fluorescein isothiocyanate-dextran concentrations and intestinal permeability decreased, and claudin-5 and ZO-1 levels in the brain and colon returned to normal levels after this treatment. This suggests that PLR and CXR can prevent brain gut-barrier disruption caused by ischemic stroke (Chen R. et al., 2019). Moreover, Rhizome Chuanxiong and the other three TCM compounds could promote NSCs proliferation in vitro, and also promote the proliferation of hippocampus in vivo, while inhibiting hyperactivity of the HPA axis (Pao et al., 2012). This suggests that the Chuanxiong may affect neurogenesis through the gut microbiota and HPA axis, but this needs further confirmation.

Actinobacteria levels are low in the human intestine, but they are extremely important to maintain intestinal homeostasis. Differences in Actinobacteria emerge early in infancy, arising particularly between cesarean and vaginal births (Gronlund et al., 1999; Kabeerdoss et al., 2013). In a clinical trial, transplantation of Bifidobacterium longum NCC3001 of Actinobacteria improved depressive manifestations and improved quality of life in patients with irritable bowel syndrome, which was associated with altered amygdala and frontal limbic activity (Pinto-Sanchez et al., 2017). This suggests that Actinobacteria could affect neurogenesis. Ginsenoside Rg3, one of the main components of red ginseng, is fermented and metabolized to ginsenoside Rd in the intestine by Bifidobacterium. After treatment with ginsenoside Rg3, serum corticosterone and adrenal cortical hormones were reduced. In the brain, 5-HT was up-regulated and norepinephrine content was reduced, leading to increased expression of central BDNF (Han et al., 2020; Sur and Lee, 2022). Simultaneously, ginsenosides Rd promoted the proliferation of hippocampal NSCs but Andrographolide but did not affect differentiation (Lin et al., 2012). Therefore, we speculate that red ginseng regulates central neurotransmitters and BDNF through the HPA axis under the action of intestinal Actinobacteria, which further affects NSCs differentiation. Paeoniflorin modulates gut microbiota in depressive rats, upregulating Roseburia abundance, and has antidepressant effects; the gut microbiota metabolizes paeoniflorin to produce benzoic acid, which can cross the BBB to regulate the CNS (Yu et al., 2019). Paeoniflorin up-regulated BDNF expression, enhanced NSCs proliferation in the hippocampus and promoted astrocyte differentiation (Chen L B. et al., 2019). Sodium benzoate can increase BDNF expression in neurons in a dose-dependent and time-dependent manner (Jana et al., 2013; Guo et al., 2020). This suggests that the benzoic acid produced by Actinobacteria metabolization of paeoniflorin may directly regulate neurogenesis. At present, there are few studies on the effects of TCM on Actinobacteria, but their role in regulating neurogenesis warrants further research.